Hyrra Features the Latest and Most Talked-About Topstories News and Headlines from Around the World.
⎯ 《 Hyrra • Com 》

List of All Articles with Tag 'mrk us'

Billionaire Texan Heir Is Helping Bring Back the Woolly Mammoth
Billionaire Texan Heir Is Helping Bring Back the Woolly Mammoth
A Texas oil heir’s quest to make Dallas a hub for biotech is showing signs of paying off,
2023-12-01 22:24
Google Alum’s AI Startup Raises $24 Million for Biotech Work
Google Alum’s AI Startup Raises $24 Million for Biotech Work
European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists
2023-11-28 19:53
A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
A Biotech Slump Is Emptying Labs and Threatening Research on New Drugs
Sangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this
2023-11-22 19:45
Blackstone Is Lead Bidder in Signature Bank Property-Loan Sale
Blackstone Is Lead Bidder in Signature Bank Property-Loan Sale
Blackstone Inc. is the frontrunner to win a roughly $17 billion portfolio of commercial-property loans from the Federal
2023-11-19 23:58
Cyber ‘Catastrophe Bonds’ Move Step Closer to Hitting Public Debt Markets
Cyber ‘Catastrophe Bonds’ Move Step Closer to Hitting Public Debt Markets
Cyber catastrophe bonds may be about to move out of the shadows of private deal-making and into the
2023-11-13 14:51
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:20
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck Discontinues Developing Drug Candidates With Sichuan Kelun After Daiichi Sankyo Deal
Merck & Co. won’t continue with two drug candidates it previously agreed to co-develop with a Chinese biotech
2023-10-23 13:49
Pfizer Cuts Guidance on Weakening Demand for Covid Antiviral Paxlovid 
Pfizer Cuts Guidance on Weakening Demand for Covid Antiviral Paxlovid 
Pfizer Inc. slashed its revenue and earnings forecasts for the year after agreeing to take Paxlovid doses back
2023-10-14 07:54